Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Pharmacogenetic genotype and phenotype frequencies in a large Danish population-based case-cohort sample

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Serotonin transporter availability increases in patients recovering from a depressive episode

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Genome-wide gene expression changes in postpartum depression point towards an altered immune landscape

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Synaptic processes and immune-related pathways implicated in Tourette syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Examining Sex-Differentiated Genetic Effects Across Neuropsychiatric and Behavioral Traits

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Leveraging both individual-level genetic data and GWAS summary statistics increases polygenic prediction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Pharmacogenetics aims to improve clinical care by studying the relationship between genetic variation and variable drug response. Large population-based datasets could improve our current understanding of pharmacogenetics from selected study populations. We provide real-world pharmacogenetic frequencies of genotypes and (combined) phenotypes of a large Danish population-based case-cohort sample (iPSYCH2012; data of the Integrative Psychiatric Research consortium). The genotyped sample consists of 77,684 individuals, of which 51,464 individuals had diagnoses of severe mental disorders (SMD case-cohort) and 26,220 were individuals randomly selected from the Danish population (population cohort). Array-based genotype data imputed to 8.4 million genetic variants was searched for a selected pharmacogenetic panel of 42 clinically relevant variants and a CYP2D6 gene deletion and duplication. We identified 19 of 42 variants. Minor allele frequencies (MAFs) were consistent with previously reported MAFs, and did not differ between SMD cases and population cohorts. Almost all individuals carried at least one genetic variant (> 99.9%) and 87% carried three or more genetic variants. When genotypes were translated into phenotypes, also > 99.9% of individuals had at least one divergent phenotype (i.e. divergent from the common phenotypes considered normal, e.g. extensive metabolizer). The high number of identified individuals with at least one pharmacogenetic variant or divergent phenotype indicates the importance of pharmacogenetic panel-based genotyping. Combined CYP2C19-CYP2D6 phenotypes revealed that 72.7% of individuals had divergent phenotypes for one or both enzymes. As CYP2D6 and CYP2C19 have an important role in the metabolism of psychotropic drugs, this indicates the relevance of pharmacogenetic testing specifically in individuals using psychotropic drugs.

OriginalsprogEngelsk
Artikelnummer294
TidsskriftTranslational psychiatry
Vol/bind11
Udgave nummer1
Sider (fra-til)294
ISSN2158-3188
DOI
StatusUdgivet - 18 maj 2021

ID: 65785179